CMA opens bipolar drug probe
Shutterstock/Angel Soler Gollonet
The UK’s antitrust authority has launched an abuse of dominance investigation into Essential Pharma after the drugmaker threatened to withdraw a lithium-based bipolar disorder medication from the market.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Subscribe now